CompletedNot Applicable

Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation

Egypt90 participantsStarted 2019-01-16

Plain-language summary

The aim of the study is to identify the role of preoperative chlorepheniramine maleate on alleviating or reducing the severity of postoperative agitation following FESS procedures.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The inclusion criteria of these patients include adult patients (age 18- 60 years), class I-II according to American society of anaesthesiologists (ASA) physical status subjected to FESS without septoplasty. Exclusion Criteria: * Exclusion criteria include; patients below 18 years old or over 60 years old, patients with ASA physical status class III-IV, morbid obesity with BMI \> 30 kgm-2 at initial hospital visit, history of neuro-psychatric ailment or chronic use of antipsychotic drugs, severe cardiovascular disease, any coagulopathies, pregnancy, history of relevant drug allergy, any possibility of anticipated difficult intubation.

What they're measuring

reduction of postoperative agitation following FESS procedures using chlorpheniramine maleate

Timeframe: Start immediately postextubation (0) minute and every 5 minute for 30 minutes after recovery),

Trial details

NCT IDNCT04293081

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-31

View on ClinicalTrials.gov More Agitated; State, Acute Reaction to Stress trials